The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

J Neurosci. 1996 Feb 1;16(3):1114-22. doi: 10.1523/JNEUROSCI.16-03-01114.1996.

Abstract

Nova-1, a protein expressed in tumors and neurons, is a target antigen in a human paraneoplastic motor disorder [paraneoplastic opsoclonus-myoclonus ataxia (POMA)]. We evaluated the relationship between the function of Nova-1 and its role as a disease antigen. We show that Nova-1 is a neuron-specific RNA-binding protein with sequence and functional similarities to FMR-1. Nova-1 mRNA is restricted to the subcortical nervous system, and the protein binds to RNA with high affinity. Nova-1 KH domains mediate this RNA binding, and point mutations within them abrogate binding. POMA disease antisera (6/6) recognize the third KH domain but not an inactive point mutant, and affinity-purified antibody blocks Nova-1 RNA binding. Thus, a cardinal feature of POMA is the production of antibodies that inhibit Nova-1-RNA interactions, suggesting such inhibition may cause the neurological disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Neoplasm / immunology*
  • Antigens, Neoplasm / chemistry
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / immunology
  • Antigens, Neoplasm / physiology*
  • Ataxia / etiology
  • Ataxia / immunology*
  • Autoantibodies / immunology*
  • Autoimmune Diseases / immunology
  • Brain Chemistry
  • Consensus Sequence
  • Epitopes / immunology
  • Humans
  • Mice
  • Molecular Sequence Data
  • Myoclonus / etiology
  • Myoclonus / immunology*
  • Neoplasms / complications
  • Neoplasms / immunology
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / immunology
  • Nerve Tissue Proteins / physiology*
  • Neuro-Oncological Ventral Antigen
  • Neurons / metabolism*
  • Ocular Motility Disorders / etiology
  • Ocular Motility Disorders / immunology*
  • Paraneoplastic Syndromes / immunology*
  • Point Mutation
  • Protein Binding
  • Protein Structure, Tertiary
  • RNA-Binding Proteins / antagonists & inhibitors
  • RNA-Binding Proteins / chemistry
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / immunology
  • RNA-Binding Proteins / physiology*
  • Ribonucleoproteins / antagonists & inhibitors
  • Ribonucleoproteins / chemistry
  • Ribonucleoproteins / genetics
  • Ribonucleoproteins / immunology
  • Ribonucleoproteins / physiology*
  • Sequence Alignment
  • Sequence Homology, Amino Acid

Substances

  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Autoantibodies
  • Epitopes
  • Nerve Tissue Proteins
  • Neuro-Oncological Ventral Antigen
  • RNA-Binding Proteins
  • Ribonucleoproteins